abu-abeeleh, J. (2015) “SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS”, European Scientific Journal, ESJ, 11(24). Available at: https://last.eujournal.org/index.php/esj/article/view/6096 (Accessed: 7 February 2026).